We’ve responded to the consultation on the Cost-Effectiveness Methodology for Vaccination Programmes and Procurement (CEMIPP) Report
Our belief is that the recommendations in the report - depending on how they are interpreted and implemented - could have a significant impact on the future of the nation’s lifesaving vaccination programme, and on how the principle of preventing disease and illness is valued as part of the overall provision of health and care. We are deeply concerned that this impact could be negative.
Our response is therefore simple - we are urging the Department of Health and Social Care (DHSC) to reject those aspects of the report that could jeopardise the UK’s lifesaving vaccination programme and that would signal a move away from the prevention of disease and illness in favour of its treatment.
Three main concerns
We have three main concerns: that the report doesn’t meet its original intentions; that it will be damaging to the UK’s lifesaving vaccination programme; and that it lacks coherence and - if implemented - could undermine confidence in the process of decision-making around changes to the UK’s vaccination programme.
As such we’re calling upon the Department of Health and Social Care to consider implementation of a lower discount rate for vaccines, now; reject recommendations that could damage the UK’s lifesaving vaccination programme; and consider developing a new long-term vision or strategy for vaccines and immunisation.
In preparing our response, we have taken account of the views of our supporters, beneficiaries and stakeholders. Many of these are angry and dismayed at the CEMIPP report and the length of time it has taken to be published.
Submit your own response
We’re encouraging individuals to submit your own response via the government’s consultation website.
We have also contributed to a collective consultation response representing the views of selected AMRC charities.
